Emrayaa Pharmaceuticals Private Limited
About Emrayaa Pharmaceuticals Private Limited
Data last updated:
Emrayaa Pharmaceuticals Private Limited is a private limited company based in Thane, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 05 September 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U85320MH2020PTC345426. Its GSTIN is 27AAGCE0677A1ZX (Maharashtra).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Dattatray Vitthalrao Posa and Ganesh Ramayya Pengonda.
Its last annual general meeting (AGM) was held on 30 September 2022, and its latest financial statements are for the year ended 31 March 2022. The registered office is at C – 705 Imperial Heights Penkarpada Near Dahisar Check Naka Mira Road East, Thane, Maharashtra, India – 401107.
As per the financials filed for FY 2022, the company reported a revenue of ₹18.97 Lakh. For the same year it recorded a net loss of ₹33.69 Lakh (net margin -177.6%) and EBITDA of -₹30.94 Lakh (EBITDA margin -163.1%).
Court records list 6 cases involving the company, including 1 filed by the company and 5 filed against it; 6 cases are pending.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressC – 705 Imperial Heights Penkarpada Near Dahisar Check Naka Mira Road East, Thane, Maharashtra, India – 401107
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Emrayaa Pharmaceuticals Private Limited
The main business activity of Emrayaa Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Emrayaa Pharmaceuticals Private Limited FY 2022 filings available
Emrayaa Pharmaceuticals Private Limited reported revenue of ₹18.97 Lakh for FY 2022.
Financial Statement Summary of Emrayaa Pharmaceuticals Private Limited
| Metrics | FY 2021-22 | FY 2020-21 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | •••• | •••• |
| Other Income | •••• | •••• |
| Total Revenue | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• |
| Employee Benefit Expense | •••• | •••• |
| Finance Costs | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• |
| Other Expenses | •••• | •••• |
| Total Expenses | •••• | •••• |
| EBITDA | -₹30.94 Lakh | •••• |
| Profit Before Tax | •••• | •••• |
| Tax Expense | •••• | •••• |
| Net Profit (PAT) | -₹33.69 Lakh | •••• |
| Balance Sheet | ||
| Share Capital | •••• | •••• |
| Reserves and Surplus | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• |
| Long-term Borrowings | •••• | •••• |
| Short-term Borrowings | •••• | •••• |
| Trade Payables | •••• | •••• |
| Total Liabilities | •••• | •••• |
| Fixed Assets | •••• | •••• |
| Investments | •••• | •••• |
| Inventories | •••• | •••• |
| Trade Receivables | •••• | •••• |
| Cash and Bank Balance | •••• | •••• |
| Total Assets | •••• | •••• |
Financial Ratios of Emrayaa Pharmaceuticals Private Limited
| Metrics | FY 2021-22 | FY 2020-21 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | -163.1% | •••• |
| Net Profit Margin | -177.6% | •••• |
| Return on Equity (ROE) | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• |
| Liquidity and Debt | ||
| Current Ratio | •••• | •••• |
| Quick Ratio | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• |
| Efficiency and Growth | ||
| Asset Turnover | •••• | •••• |
| Receivable Days | •••• | •••• |
| Payable Days | •••• | •••• |
| Inventory Days | •••• | •••• |
| Revenue Growth | •••• | •••• |
| Net Profit Growth | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Emrayaa Pharmaceuticals are in the company report.
Financial statements from FY 2021
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Emrayaa Pharmaceuticals Private Limited
Emrayaa Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Mazing Pharmaceuticals (OPC) Private Limited | ₹19.01 Lakh (FY 2025) | •••• | •••• | 492.0% | •••• | Indore, Madhya Pradesh, India |
| Karthikeya Drugs & Pharmaceuticals Private Limited | ₹19 Lakh (FY 2019) | •••• | •••• | -12.0% | •••• | Hyderabad, Telangana, India |
| Megrez Pharmaceuticals & Chemicals Private Limited | ₹19 Lakh (FY 2025) | •••• | •••• | 1.0% | •••• | Noida, Uttar Pradesh, India |
| MSPS Pharma Lab Private Limited | ₹18.99 Lakh (FY 2025) | •••• | •••• | 142.0% | •••• | Hyderabad, Telangana, India |
| Winystra Pharmaceuticals Private Limited | ₹18.97 Lakh (FY 2025) | •••• | •••• | 6.0% | •••• | Bangalore, Karnataka, India |
| Emrayaa Pharmaceuticals Private Limited this company | ₹18.97 Lakh (FY 2022) | •••• | •••• | •••• | Thane, Maharashtra, India | |
| Sunsol Pharma Private Limited | ₹18.92 Lakh (FY 2025) | •••• | •••• | 633.0% | •••• | Dahod, Gujarat, India |
| Triple Twelve Pharmaceuticals Private Limited | ₹18.91 Lakh (FY 2025) | •••• | •••• | -32.0% | •••• | Kodungallur, Kerala, India |
| Maharaja Aggarsain Pharmaceuticals Private Limited | ₹18.91 Lakh (FY 2021) | •••• | •••• | 29.0% | •••• | Hansi, Haryana, India |
| Safecure Iconic Private Limited | ₹18.91 Lakh (FY 2025) | •••• | •••• | 238.0% | •••• | Delhi, India |
| Emuric Pharmaceuticals Private Limited | ₹18.9 Lakh (FY 2025) | •••• | •••• | -16.0% | •••• | Patna, Bihar, India |
Peers are the five companies nearest above and the five nearest below Emrayaa Pharmaceuticals by revenue in the Pharma industry (Formulations, Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of Emrayaa Pharmaceuticals Private Limited
Emrayaa Pharmaceuticals has 2 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Dattatray Vitthalrao Posa | Director | 17 Jul 2021 | 5 Years 2 Months | Current |
| Ganesh Ramayya Pengonda Also directs: Yatharth - the Insights Story Private Limited | Director | 05 Sep 2020 | 6 Years 1 Months | Current |
Charges & Borrowings of Emrayaa Pharmaceuticals Private Limited
Emrayaa Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Legal Cases of Emrayaa Pharmaceuticals Private Limited
Emrayaa Pharmaceuticals Private Limited has 6 court cases on record: 1 filed by Emrayaa Pharmaceuticals, 5 filed against it. All cases are pending. Status as checked between 02 Oct 2026 and 04 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 6 | 5 | 6 |
Cases on record (4 of 6)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Bombay High Court | Interim or miscellaneous application | Filed against the company by Sapphire Pharmaceuticals | Pending |
| Bombay High Court | Court case (COMIP) | Filed against the company by Sapphire Pharmaceuticals | Pending |
| Bombay High Court | Court case (CRR) | Filed against the company by Sapphire Pharmaceuticals | Pending |
| Bombay High Court | Interim or miscellaneous application | Filed by the company against Sapphire Pharmaceuticals | Pending |
Full case history
All 6 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Emrayaa Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Emrayaa Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Emrayaa Pharmaceuticals Private Limited
Emrayaa Pharmaceuticals Private Limited has 7 board changes on record since 2020: 2 appointments and 5 cessations. The latest: Dattatray Vitthalrao Posa ceased to be Additional Director on 30 Dec 2021.
Credit Ratings, Litigation & Regulatory Alerts for Emrayaa Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Emrayaa Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Emrayaa Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Emrayaa Pharmaceuticals Private Limited
Emrayaa Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAGCE0677A1ZX | Maharashtra | Active | 09 Sep 2021 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Emrayaa Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Emrayaa Pharmaceuticals Private Limited
Emrayaa Pharmaceuticals is an active private limited company based in Thane, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 05 September 2020 (6+ years old) and is registered under CIN U85320MH2020PTC345426.
Emrayaa Pharmaceuticals reported revenue of ₹18.97 Lakh for FY 2022.
Emrayaa Pharmaceuticals has 2 current directors:
- Dattatray Vitthalrao Posa - Director
- Ganesh Ramayya Pengonda - Director
Emrayaa Pharmaceuticals reported a net loss of ₹33.69 Lakh (net margin -177.6%) and EBITDA of -₹30.94 Lakh (EBITDA margin -163.1%) for FY 2022, as per its filed financial statements.
The GSTIN of Emrayaa Pharmaceuticals is 27AAGCE0677A1ZX, registered in Maharashtra.
The CIN (Corporate Identification Number) of Emrayaa Pharmaceuticals is U85320MH2020PTC345426. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Emrayaa Pharmaceuticals has 6 court cases on record: 1 filed by the company and 5 filed against it. 6 are pending.
Emrayaa Pharmaceuticals was incorporated on 05 September 2020, making it 6+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Emrayaa Pharmaceuticals by revenue are Mazing Pharmaceuticals (OPC) Private Limited, Karthikeya Drugs & Pharmaceuticals Private Limited, Megrez Pharmaceuticals & Chemicals Private Limited, MSPS Pharma Lab Private Limited, Winystra Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Formulations, Pharmaceuticals).
Dattatray Vitthalrao Posa ceased to be Additional Director on 30 Dec 2021. Gangadhar Laxmipati Devasani ceased to be Additional Director on 30 Dec 2021. Yallappa Vithal Nukal ceased to be Additional Director on 30 Dec 2021. Emrayaa Pharmaceuticals has 7 board changes on record in total.
The registered office of Emrayaa Pharmaceuticals is at C – 705 Imperial Heights Penkarpada Near Dahisar Check Naka Mira Road East, Thane, Maharashtra, India – 401107.